Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMR Assessment of Microvascular Dysfunction in Nonischemic Cardiomyopathy
NCT03249272Phase 4Terminated
- Sponsor
- Duke University
- Start
- Sep 2017
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
Phase 4, open-label trial in hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM) and Coronary Microvascular Dysfunction (CMD) (3 arms), sponsored by Duke University. Primary endpoint: Prevalence of Microvascular Dysfunction at Day 1. Started Sep 2017; status: terminated.
02
Conditions
hypertrophic cardiomyopathy (HCM)dilated cardiomyopathy (DCM)Coronary Microvascular Dysfunction (CMD)
Beyond the preview
Go deeper on NCT03249272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03249272.